Jeff Bezos (AP Photo/Tony Gutierrez)

There's a new an­ti-ag­ing up­start in town — and it's re­port­ed­ly backed by Ama­zon bil­lion­aire Jeff Be­zos

Go­ing to space wasn’t enough. Mid­dle-aged bil­lion­aire Jeff Be­zos wants to ex­tend hu­man life — and to do so, he’s re­port­ed­ly back­ing the lat­est en­trant in­to Sil­i­con Val­ley’s bur­geon­ing race to slow ag­ing.

A stealthy biotech called Al­tos Labs launched ear­li­er this year with at least $270 mil­lion and a slate of longevi­ty ex­perts on board to pur­sue bi­o­log­i­cal re­pro­gram­ming tech­nol­o­gy, ac­cord­ing to a scoop by the MIT Tech­nol­o­gy Re­view. Un­named sources told the Tech­nol­o­gy Re­view that Al­tos will es­tab­lish sites in the Bay Area, San Diego, Cam­bridge, UK, and Japan. In ad­di­tion to Be­zos, the op­er­a­tion is al­so ru­mored to be backed by Russ­ian bil­lion­aire Yuri Mil­ner, who’s in­vest­ed in Face­book and Twit­ter.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.